High‐dose, short‐term, anti‐inflammatory treatment with dexamethasone reduces growth and augments the effects of 5‐fluorouracil on dimethyl‐α‐benzanthracene‐induced mammary tumors in rats

References

• Jain R. K. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039–51
   PubMed Web of Science ®Google Scholar
• Wiig H., Tveit E., Hultborn R., Reed R., Weiss L. Interstitial fluid pressure in DMBA‐induced rat mammary tumors. Scand J Clin Lab Invest 1982; 42: 159–64
   PubMed Web of Science ®Google Scholar
• Heldin C‐H., Rubin K., Pietras K., Østman A. High interstitial fluid pressure: an obstacle in cancer therapy. Nature Rev 2004; 4: 808–13
   Google Scholar
• Rubin K., Sjoquist M., Gustafsson A. M., Isaksson B., Salvessen G., Reed R. K. Lowering of tumoral interstitial fluid pressure by prostaglandin E(1) is paralleled by an increased uptake of (51)Cr‐EDTA. Int J Cancer 2000; 1: 636–43
   Google Scholar
• Salnikov A. V., Iversen V. V., Koisti M., Sundberg C., Johansson L., Stuhr L. B., et al. Lowering of tumor interstitial fluid pressure specifically augments efficiency of chemotherapy. Faseb Journal 2003; 17: 1756–8
   PubMed Web of Science ®Google Scholar
• Pietras K., Østman A., Sjøquist M., Buchdunger E., Reed R. K., Heldin C. H., et al. Inhibition of platelet‐derived growth factor receptor reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001; 61: 2929–34
   PubMed Web of Science ®Google Scholar
• Pietras K., Rubin K., Sjøblom T., Buchdunger E., Sjøquist M., Heldin C. H., et al. Inhibition of PDGF receptor signalling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 2002; 62: 5476–84
   PubMed Web of Science ®Google Scholar
• Shapiro W. R., Posner J. B. Corticosteroid hormones. Effects in an experimental brain tumor. Arch Neurol 1974; 30: 217–21
   PubMed Web of Science ®Google Scholar
• Kristjansen P. E. G., Boucher Y., Jain R. K. Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. Cancer Res 1993; 53: 4764–6
   PubMed Web of Science ®Google Scholar
• Hofmann J., Kaiser U., Maasberg M., Havemann K. Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. Eur J Cancer 1995; 31: 2053–8
   Google Scholar
• Denis M. G., Chadeneau C., Blanchardie P., Lustenberger P. Biological effects of glucocorticoid hormones on two rat colon adenocarcinoma cell lines. J Steroid Biochem Mol Biol 1992; 41: 739–45
   Google Scholar
• Distelhorst G. W. Glucocorticosteroids induce DNA fragmentation in human lymphoid leukemia cells. Blood 1988; 72: 1305–9
   PubMed Web of Science ®Google Scholar
• Fadnes H. O., Reed R. K., Aukland K. Interstitial fluid pressure in rats measured with a modified wick technique. Microvasc Res 1977; 14: 27–36
   PubMed Web of Science ®Google Scholar
• Sundberg C., Ivarsson M., Gerdin B., Rubin K. Pericytes as collagen‐producing cells in excessive dermal scarring. Lab Invest 1996; 74: 52–466
   Google Scholar
• Aukland K., Reed R. K. Interstitial‐lymphatic mechanisms in the control of extracellular fluid volume [review]. Physiol Rev 1993; 73: 1–78
   PubMed Web of Science ®Google Scholar
• Berg A., Ekwall A. K., Rubin K., Stjernschantz, Reed R. K. Effect of PGE1, PGI2 and PGF2α analogs on collagen gel compaction in vitro and interstitial pressure in vivo. Am J Physiol 1998; 274: 663–71
   PubMed Web of Science ®Google Scholar
• Kristensen C. A., Nozue M., Boucher Y., Jain R. K. Reduction of interstitial fluid pressure after TNF‐α treatment of three human melanoma xenografts. Br J Cancer 1996; 74: 533–6
   PubMed Web of Science ®Google Scholar
• Lee I., Boucher Y., Jain R. K. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res 1992; 52: 3237–40
   PubMed Web of Science ®Google Scholar
• Lee C. G., Heijn M., di Tomaso E., Griffon‐Etienne G., Ancukiewicz M., Koike C., et al. Anti‐vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 2000; 60: 5565–70
   PubMed Web of Science ®Google Scholar
• Lammerts E., Roswall P., Sundberg C., Gotwals P. J., Koteliansky V. E., Reed R. K., et al. Interference with TGF‐beta 1 and ‐beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma. Int J Cancer 2002; 102: 453–462
   PubMedGoogle Scholar
• Salnikov A. V., Roswall P., Sunberg C., Gardner H., Heldin N‐E., Rubin K. Inhibition of TGF‐β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma. Lab Invest 2005; 85: 512–21
   PubMedGoogle Scholar
• Rippe B., Haraldsson B. Transport of macromolecules across microvascular walls: the two‐pore theory. Physiology Rev 1994; 74: 163–219
   PubMed Web of Science ®Google Scholar
• Jain R. K. Normalizing tumor vasculature with anti‐angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001; 7: 987–9
   PubMed Web of Science ®Google Scholar
• Kawashima H., Ogose A., Hayami T., Yamagiwa H., Hatano H., Hotta T., et al. Effect of dexamethasone on growth inhibition and chondrogenic maturation of human chondrosarcoma. J Orthop Sci 2003; 8: 341–5
   Google Scholar
• Kudawara I., Ueda T., Yoshikawa H., Miyama T., Yamamoto T., Nishizawa Y. In vivo inhibition of tumour growth by dexamethasone in murine osteosarcomas. Eur J Cancer 2001; 37: 1703–8
   Google Scholar
• Tobelem G. Endothelial cell growth: biology and pharmacology in relation to angiogenesis. Blood Coagul Fibrinolysis 1990; 1: 703–5
   Google Scholar
• Nishimura K., Nonomura N., Satoh E., Harada Y., Nakayama M., Tokizare T., et al. Potential mechanism for the effects of dexamethasone on growth of androgen‐independent prostate cancer. J Natl Cancer Inst 2001; 22: 1739–46
   Google Scholar
• Yu W. D., McElwain M. C., Modzelewski R. A., Russell D. M., Smith D. C., Trump D. L., et al. Enhancement of 1,25‐dihydroxyvitamin D3‐mediated antitumor activity with dexamethasone. J Natl Cancer Inst. (Bethesda) 1998; 90: 134–41
   Google Scholar
• Oikarinen A., Autio P. New aspects of the mechanism of corticosteroid‐induced dermal atrophy. Clin Exp Dermatol 1991; 16: 416–9
   PubMed Web of Science ®Google Scholar
• Bouma‐ter Steege J. C., Baeten C. I., Thijssen V. L., Satijn S. A., Verhoeven I. C., Hillen H. F., et al. Angiogenic profile of breast carcinoma determines leukocyte infiltration. Clin Cancer Res 2004; 10: 7171–8
   PubMed Web of Science ®Google Scholar
• Badie B., Schartner J. M., Paul J., Bartley B. A., Vorpahl J., Preston J. K. Dexamethasone‐induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. J Neurosurg 2000; 93: 634–9
   PubMedGoogle Scholar
• Nupponen I., Repo H., Kari A., Pohjavuori M., Andersson S. Early dexamethasone decreases expression of activation markers on neutrophils and monocytes in preterm infants. Acta Paediatr 2002; 9: 1200–7
   Google Scholar
• Walsh C. J., Wyffels J. T., Bodine A. B., Luer C. A. Dexamethasone‐induced apoptosis in immune cells from peripheral circulation and lymphomyeloid tissues of juvenile clearnose skates, Raja eglanteria. Dev Comp Immunol 2002; 26: 623–33
   Google Scholar
• Li H‐P., He G‐J., Yi X‐H., Paplan A. P. The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin‐induced pulmonary fibrosis in rats. Respirology 2004; 9: 25–32
   PubMed Web of Science ®Google Scholar
• Lin E. Y., Pollard J. W. Macrophages: modulators of breast cancer progression. Novartis Found Symp 2004; 256: 158–68
   PubMedGoogle Scholar